Rosiglitazone attenuated endothelin-1-induced vasoconstriction of pulmonary arteries in the rat model of pulmonary arterial hypertension via differential regulation of et-1 receptors

PPAR Research

Volumn 2014, Issue , 2014, Pages

  Liu, Yahan ^a   Tian, Xiao Yu ^b   Huang, Yu ^b   Wang, Nanping ^a,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVASOCONSTRICTIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HYPOXIA; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; WESTERN BLOTTING;

EID: 84896266248     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2014/374075     Document Type: Article

References (41)

1. Farber H. W., Loscalzo J., Mechanisms of disease: pulmonary arterial hypertension. New England Journal of Medicine 2004 351 16 1655 1665 2-s2.0-5344233478 10.1056/NEJMra035488 (Pubitemid 39350426)
2. Miyauchi T., Yorikane R., Sakai S., Sakurai T., Okada M., Nishikibe M., Yano M., Yamaguchi I., Sugishita Y., Goto K., Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circulation Research 1993 73 5 887 897 2-s2.0-0027449163 (Pubitemid 23306133)
3. Stewart D. J., Levy R. D., Cernacek P., Langleben D., Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Annals of Internal Medicine 1991 114 6 464 469 2-s2.0-0026034713
4. Giaid A., Yanagisawa M., Langleben D., Michel R. P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W. P., Stewart D. J., Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. New England Journal of Medicine 1993 328 24 1732 1739 2-s2.0-0027324745 10.1056/NEJM199306173282402 (Pubitemid 23170122)
5. Stelzner T. J., O'Brien R. F., Yanagisawa M., Sakurai T., Sato K., Webb S., Zamora M., McMurtry I. F., Fisher J. H., Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. American Journal of Physiology 1992 262 5 L614 L620 2-s2.0-0026635055
6. Bonvallet S. T., Zamora M. R., Hasunuma K., Sato K., Hanasato N., Anderson D., Sato K., Stelzner T. J., BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. American Journal of Physiology 1994 266 4 H1327 H1331 2-s2.0-0028300556 (Pubitemid 24150759)
7. DiCarlo V. S., Chen S.-J., Qing Cheng Meng Q. C. M., Durand J., Yano M., Chen-Y. F., Oparil S., ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. American Journal of Physiology 1995 269 5 L690 L697 2-s2.0-0028844533
8. Ivy D. D., Parker T. A., Ziegler J. W., Galan H. L., Kinsella J. P., Tuder R. M., Abman S. H., Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. Journal of Clinical Investigation 1997 99 6 1179 1186 2-s2.0-0030894717 (Pubitemid 27142753)
9. Davie N., Haleen S. J., Upton P. D., Polak J. M., Yacoub M. H., Morrell N. W., Wharton J., ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells. American Journal of Respiratory and Critical Care Medicine 2002 165 3 398 405 2-s2.0-0036468709 (Pubitemid 34118516)
10. Soma S., Takahashi H., Muramatsu M., Oka M., Fukuchi Y., Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. American Journal of Respiratory Cell and Molecular Biology 1999 20 4 620 630 2-s2.0-0033110922 (Pubitemid 129495650)
11. Rondelet B., Kerbaul F., Motte S., Van Beneden R., Remmelink M., Brimioulle S., McEntee K., Wauthy P., Salmon I., Ketelslegers J.-M., Naeije R., Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 2003 107 9 1329 1335 2-s2.0-0037432296 10.1161/01.CIR.0000053443.27512.33 (Pubitemid 36314419)
12. Lutz J., Gorenflo M., Habighorst M., Vogel M., Lange P. E., Hocher B., Endothelin-1- and endothelin-receptors in lung biopsies of patients with pulmonary hypertension due to congenital heart disease. Clinical Chemistry and Laboratory Medicine 1999 37 4 423 428 2-s2.0-0032891535 10.1515/CCLM.1999.069 (Pubitemid 29218962)
13. Wong J., Reddy V. M., Hendricks-Munoz K., Liddicoat J. R., Gerrets R., Fineman J. R., Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow. American Journal of Physiology 1995 269 6 H1965 H1972 2-s2.0-0029585482 (Pubitemid 26023212)
14. Ivy D. D., Ziegler J. W., Dubus M. F., Fox J. J., Kinsella J. P., Abman S. H., Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatric Research 1996 39 3 435 442 2-s2.0-0030047262 (Pubitemid 26070836)
15. Ivy D. D., Le Cras T. D., Horan M. P., Abman S. H., Chronic intrauterine pulmonary hypertension increases preproendothelin-1 and decreases endothelin B receptor mRNA expression in the ovine fetal lung. Chest 1998 114 1, supplement 65 2-s2.0-17444436466
16. Hansmann G., Zamanian R. T., PPARgamma activation: a potential treatment for pulmonary hypertension. Science Translational Medicine 2009 1 12 12 14 2-s2.0-77954594805 10.1126/scitranslmed.3000267
17. Wang N., Verna L., Chen N.-G., Chen J., Li H., Forman B. M., Stemerman M. B., Constitutive activation of peroxisome proliferator-activated receptor- γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. Journal of Biological Chemistry 2002 277 37 34176 34181 2-s2.0-0037072826 10.1074/jbc.M203436200
18. Li J., Wang N., Peroxisome proliferator-activated receptor- γ in vascular biology. Cardiovascular and Hematological Disorders 2007 7 2 109 117 2-s2.0-34347375795 (Pubitemid 47024126)
19. Hamblin M., Chang L., Fan Y., Zhang J., Chen Y. E., PPaRs and the cardiovascular system. Antioxidants and Redox Signaling 2009 11 6 1415 1452 2-s2.0-65349091310 10.1089/ars.2008.2280
20. Ameshima S., Golpon H., Cool C. D., Chan D., Vandivier R. W., Gardai S. J., Wick M., Nemenoff R. A., Geraci M. W., Voelkel N. F., Peroxisome proliferator-activated receptor gamma (PPAR γ) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circulation Research 2003 92 10 1162 1169 2-s2.0-0038389113 10.1161/01.RES.0000073585.50092.14 (Pubitemid 36665863)
21. Kim E. K., Lee J.-H., Oh Y.-M., Lee Y.-S., Lee S.-D., Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats. Respirology 2010 15 4 659 668 2-s2.0-77951725877 10.1111/j.1440-1843.2010.01756.x
22. Nisbet R. E., Bland J. M., Kleinhenz D. J., Mitchell P. O., Walp E. R., Sutliff R. L., Hart C. M., Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. American Journal of Respiratory Cell and Molecular Biology 2010 42 4 482 490 2-s2.0-77950485024 10.1165/rcmb.2008- 0132OC
23. Hansmann G., de Jesus Perez V. A., Alastalo T.-P., Alvira C. M., Guignabert C., Bekker J. M., Schellong S., Urashima T., Wang L., Morrell N. W., Rabinovitch M., An antiproliferative BMP-2/PPAR γ /apoE axis in human and murine SMCs and its role in pulmonary hypertension. Journal of Clinical Investigation 2008 118 5 1846 1857 2-s2.0-43049092988 10.1172/JCI32503 (Pubitemid 351632387)
24. Crossno J. T. Jr., Garat C. V., Reusch J. E. B., Morris K. G., Dempsey E. C., McMurtry I. F., Stenmark K. R., Klemm D. J., Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. American Journal of Physiology 2007 292 4 L885 L897 2-s2.0-34247282656 10.1152/ajplung.00258.2006 (Pubitemid 46608235)
25. Hansmann G., Wagner R. A., Schellong S., Perez V. A. D. J., Urashima T., Wang L., Sheikh A. Y., Suen R. S., Stewart D. J., Rabinovitch M., Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor- γ activation. Circulation 2007 115 10 1275 1284 2-s2.0-33947731898 10.1161/CIRCULATIONAHA.106.663120 (Pubitemid 46594772)
26. Delerive P., Martin-Nizard F., Chinetti G., Trottein F., Fruchart J.-C., Najib J., Duriez P., Staels B., Peroxisome proliferator-activated receptor activators inhibit thrombin- induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circulation Research 1999 85 5 394 402 2-s2.0-0033520304 (Pubitemid 29409616)
27. Martin-Nizard F., Furman C., Delerive P., Kandoussi A., Fruchart J. C., Staels B., Duriez P., Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells. Journal of Cardiovascular Pharmacology 2002 40 6 822 831 2-s2.0-0036890882 10.1097/00005344-200212000-00003 (Pubitemid 35365080)
28. Tian J., Wong W. T., Tian X. Y., Zhang P., Huang Y., Wang N., Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin b receptor. Hypertension 2010 56 1 129 135 2-s2.0-77953810565 10.1161/HYPERTENSIONAHA.110.150375
29. Davenport A. P., International Union of Pharmacology-29. Update on endothelin receptor nomenclature. Pharmacological Reviews 2002 54 2 219 226 2-s2.0-0036266042 10.1124/pr.54.2.219 (Pubitemid 34575711)
30. Hosoda K., Nakao K., Hiroshi-Arai H.-A., Suga S., Ogawa Y., Mukoyama M., Shirakami G., Saito Y., Nakanishi S., Imura H., Cloning and expression of human endothelin-1 receptor cDNA. FEBS Letters 1991 287 1-2 23 26 2-s2.0-0025912582 10.1016/0014-5793(91)80007-P
31. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., Marumo F., Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. Journal of Clinical Investigation 1993 91 4 1367 1373 2-s2.0-0027299798 (Pubitemid 23127334)
32. Dupuis J., Goresky C. A., Fournier A., Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. Journal of Applied Physiology 1996 81 4 1510 1515 2-s2.0-0029847636 (Pubitemid 26349600)
33. Hynynen M. M., Khalil R. A., The vascular endothelin system in hypertension-recent patents and discoveries. Recent Patents on Cardiovascular Drug Discovery 2006 1 1 95 108 2-s2.0-39049149953 10.2174/157489006775244263
34. Clozel M., Gray G. A., Breu V., Loffler B.-M., Osterwalder R., The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochemical and Biophysical Research Communications 1992 186 2 867 873 2-s2.0-0026612994 10.1016/0006-291X(92)90826-7
35. Dunbar Ivy D., Yanagisawa M., Gariepy C. E., Gebb S. A., Colvin K. L., McMurtry I. F., Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. American Journal of Physiology 2002 282 4 L703 L712 2-s2.0-0036082822 (Pubitemid 34665585)
36. Ivy D. D., McMurtry I. F., Colvin K., Imamura M., Oka M., Lee D.-S., Gebb S., Jones P. L., Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension. Circulation 2005 111 22 2988 2996 2-s2.0-20444434392 10.1161/CIRCULATIONAHA.104.491456 (Pubitemid 40814193)
37. Nishida M., Okada Y., Akiyoshi K., Eshiro K., Takaoka M., Gariepy C. E., Yanagisawa M., Matsumura Y., Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats. European Journal of Pharmacology 2004 496 1 159 165 2-s2.0-16644395875 10.1016/j.ejphar.2004.06.028 (Pubitemid 39024328)
38. Opitz C. F., Ewert R., Kirch W., Pittrow D., Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter? European Heart Journal 2008 29 16 1936 1948 2-s2.0-49749102732 10.1093/eurheartj/ehn234
39. Okada M., Yamashita C., Okada M., Okada K., Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension. Circulation 1995 92 1 114 119 2-s2.0-0029066122
40. Attinà T., Camidge R., Newby D. E., Webb D. J., Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart 2005 91 6 825 831 2-s2.0-20044366257 10.1136/hrt.2004.053991 (Pubitemid 40769240)
41. Liu Y., Tian X.Y., Mao G., Peroxisome proliferator-activated receptor-gamma ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor. Hypertension 2012 60 6 1471 1478 10.1161/HYPERTENSIONAHA.112.198887